Adaptive Immune Responses Associated with the Central Nervous System Pathology of Gulf War Illness Apr 7, 2026
Targeting sirtuin activity with nicotinamide riboside reduces neuroinflammation in a GWI mouse model Apr 7, 2026
Oleoylethanolamide treatment reduces neurobehavioral deficits and brain pathology in a mouse model of Gulf War Illness Apr 2, 2026
Phospholipid profiling of plasma from GW veterans and rodent models to identify potential biomarkers of Gulf War Illness Mar 25, 2026
